Advancements in cancer research has come a mighty long way. This disease has ruined the lives of millions for many years, but today is a new day. The 21st century has given doctors more technology to work with, and this technology has scored big time. Dr. Clay Siegall, president and CEO of Seattle Genetics, is one of the most successful individuals in the fight against cancer. He has supreme knowledge and expertise of the industry as a whole thanks to his educational background. Dr. Siegall is a well-accomplished doctor, scientist, businessman and futurist. He has a Ph.D in Genetics, and he has a B.S. in Zoology.
Seattle Genetics is the leading biotech cancer research organization in the world, and its advanced antibody-based therapies are making a world of difference. These therapies are known as antibody-drug conjugates, and they’ve changed the game for cancer patients. ADCETRIS, the company’s top drug, is now being distributed on a worldwide scale thanks to Dr. Siegall. By securing multiple strategic licenses with numerous pharmaceutical companies, up to 65 countries can treat cancer patients with this exceptional drug. The company also has many more drugs in the development stages. Rigorous research, drug development and scientific innovation play a crucial role on how things get done. Helping patients who suffer with the pain and sickening illnesses is the goals. Dr. Siegall has a strong influence in this community, and he uses his influence to make sure that cancer therapies are prioritized.
In addition to his work in the community, Dr. Siegall uses his blog to keep the general public informed on what’s happening within the industry. Any breaking news or quick updates can be found here, but he also spends time blogging about random news stories. All in all, this well-rounded individual is a class act, and he’s definitely in a class of his own.